Comparison of Methods for Handling Missing Covariate Data
Journal Title: The AAPS Journal - Year 2013, Vol 15, Issue 4
Abstract
Missing covariate data is a common problem in nonlinear mixed effects modelling of clinical data. The aim of this study was to implement and compare methods for handling missing covariate data in nonlinear mixed effects modelling under different missing data mechanisms. Simulations generated data for 200 individuals with a 50% difference in clearance between males and females. Three different types of missing data mechanisms were simulated and information about sex was missing for 50% of the individuals. Six methods for handling the missing covariate were compared in a stochastic simulations and estimations study where 200 data sets were simulated. The methods were compared according to bias and precision of parameter estimates. Multiple imputation based on weight and response, full maximum likelihood modelling using information on weight and full maximum likelihood modelling where the proportion of males among the individuals lacking information about sex was estimated (EST) gave precise and unbiased estimates in the presence of missing data when data were missing completely at random or missing at random. When data were missing not at random, the only method resulting in low bias and high parameter precision was EST.
Authors and Affiliations
Åsa M. Johansson, Mats O. Karlsson
Keywords
Related Articles
- EP ID EP681179
- DOI 10.1208/s12248-013-9526-y
- Views 88
- Downloads 0
Dissolution Testing for Generic Drugs: An FDA Perspective
In vitro dissolution testing is an important tool used for development and approval of generic dosage forms. The objective of this article is to summarize how dissolution testing is used for the approval of safe and effe...
Effect of PEG Surface Conformation on Anticancer Activity and Blood Circulation of Nanoemulsions Loaded with Tocotrienol-Rich Fraction of Palm Oil
Tocotrienol-rich fraction of palm oil, which contains the isomers of vitamin E, was shown to possess potent anticancer activity against mammary adenocarcinoma cell lines. Its clinical use, however, is limited by poor ora...
Application of the Biopharmaceutical Classification System in Clinical Drug Development—An Industrial View
The biopharmaceutical classification system (BCS) classifies compounds based on their solubility and permeability. Regulatory agencies and health organizations have utilized this classification system to allow dissolutio...
Regulatory Considerations for Approval of Generic Inhalation Drug Products in the US, EU, Brazil, China, and India
This article describes regulatory approaches for approval of “generic” orally inhaled drug products (OIDPs) in the United States, European Union, Brazil, China and India. While registration of a generic O...
The influence of market exclusivity on drug availability and medical innovations
The interpretation and application of intellectual property laws is enormously complex in the pharmaceutical industry, with companies needing to obtain multiple patents to fully protect their innovations. While patents p...